Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics.
暂无分享,去创建一个
R Langer | R. Langer | K. Leong | B. Brott | K W Leong | B C Brott | Robert Langer | Kam W. Leong
[1] K. Himmelstein,et al. Controlled release from erod1ble poly(ortho ester) drug delivery systems , 1984 .
[2] G L Kimmel,et al. Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo. , 1981, Biomaterials.
[3] J. Heller,et al. Release of norethindrone from poly(ortho esters) , 1981 .
[4] T. Whateley,et al. Formation of poly(butyl 2-cyanoacrylate) microcapsules and the microencapsulation of aqueous solutions of [125I]-labelled proteins , 1981 .
[5] A. Florence,et al. In vitro heterogeneous degradation of poly(n‐alkyl α‐cyanoacrylates) , 1980 .
[6] J. Koenig,et al. Infrared studies of chain folding in polymers. v. polyhexamethylene adipamide , 1968 .
[7] N. Yoda,et al. Synthesis of Polyanhydride. I. Mixed Anhydride of Aromatic and Aliphatic Dibasic Acids , 1959 .
[8] R Langer,et al. Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. , 1986, Journal of biomedical materials research.
[9] Jorge Heller. Controlled release of biologically active compounds from bioerodible polymers. , 1980, Biomaterials.
[10] Robert Langer,et al. INVITED REVIEW POLYMERIC DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE , 1980 .